Patents by Inventor Christophe Andree

Christophe Andree has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transfection system
    Publication number: 20040043007
    Abstract: The present invention relates to a method of preparing a composition for wound healing, and for repairing and regenerating human and animal tissue, said method comprising the following steps:
    Type: Application
    Filed: September 18, 2003
    Publication date: March 4, 2004
    Inventors: Christoph Andree, Matthias Voight, Bjoern G. Stark
  • Wound healing
    Patent number: 5661132
    Abstract: A DNA molecule encoding a secretable mature epidermal growth factor (EGF) polypeptide is delivered to a skin wound. The cells that take up the recombinant DNA construct express soluble EGF that is secreted into surrounding fluid. The presence of the EGF accelerates, by a statistically significant amount, the healing time of a wound treated in this manner.The DNA molecule can be a genetic construction that expresses an EGF encoding portion that differs from the naturally occurring EGF precursor gene in that the only coding region retained from the precursor gene is that of the mature EGF polypeptide. Amino-terminal EGF-like repeats and the carboxy-terminal hydrophobic sequence that anchors natural EGF to the cell membrane are not present in the genetic construction.
    Type: Grant
    Filed: November 22, 1994
    Date of Patent: August 26, 1997
    Assignee: Auragen, Inc.
    Inventors: Elof Eriksson, Christophe Andree, William F. Swain, Michael D. Macklin